Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. J. Vyas is active.

Publication


Featured researches published by J. J. Vyas.


British Journal of Cancer | 1996

Multicentricity of breast cancer: whole-organ analysis and clinical implications

Js Vaidya; J. J. Vyas; Roshni Chinoy; N Merchant; Op Sharma; Indraneel Mittra

We studied the spatial relationship within the breast between multicentric foci (MCF) and the primary tumour in 30 modified radical mastectomy specimens using Egans correlated pathological-radiological method using 5 mm slices of the whole breast. The relative positions within the breast of the primary tumour and MCF were used to calculate the relative distribution of primary tumour and MCF in the four quadrants of the breast and the per cent breast volume that would be required to be excised to include all MCF. Nineteen (63%) breast harboured MCF. The relative distribution of primary tumour and MCF in the four breast quadrants was significantly different (P = 0.034). MCF were present beyond the index quadrant (25% of breast volume including the tumour) in as many as 79% (15/19) of breasts that harboured MCF; and in half the cases (15/30) when all breast were considered. This is in variance with the suggestion put forward previously that MCF are contained within the index quadrant in 90% of cases. Although the number of patients in the present series is small, the probability of our finding being due to play of chance is 1 in 1500. In a large series of breast conservation studies > 90% of early breast recurrences have been found to occur in the index quadrant. Our finding, that in half the patients (15/30) MCF are present in quadrants other than the index quadrant, suggests that MCF do not give rise to early breast recurrence.


Ejso | 1998

Prediction of nipple and areola involvement in breast cancer

J. J. Vyas; Roshni Chinoy; Js Vaidya

AIMS To find a pre-operative test for nipple and areola involvement in breast cancer. METHODS Areola-tumour distance was measured in 140 consecutive patients (median age 45, range: 23-83) undergoing a mastectomy. We analysed whether nipple and areola correlated with areola-tumour distance, tumour size, nodal status, perinodal involvement and lymphatic embolization. RESULTS The nipple was involved in 22 (16%) cases and this correlated with tumour size, number of lymph nodes, perinodal extension and presence of lymphatic emboli. In all these 22 cases, the tumour was within 2.5 cm of the areola. Tumour size, however, could not predict nipple involvement in tumours within 2.5 cm of the areolar edge. CONCLUSIONS In the one-fifth of cases where the tumour is over 2.5 cm from the areola, preserving the nipple and areola for reconstruction may be worthwhile. In remaining cases, some other predictive test for nipple involvement would be necessary.


Ejso | 1996

Role of ultrasonography to detect axillary node involvement in operable breast cancer

Js Vaidya; J. J. Vyas; Meenakshi Thakur; Kamlesh C. Khandelwal; Indraneel Mittra

Prompted by the concern about unnecessary axillary dissections, we prospectively studied the accuracy of clinical examination (CE) and conventional ultrasonography (USG, 7.5 MHz), to diagnose pre-operatively metastatic axillary lymph nodes in 200 operable breast cancer patients. USG had higher specificity (90% vs 77%, P = 0.025) and higher positive predictive value (ppv = 90% vs 76%, P = 0.02) than CE. Together, CE + USG had higher sensitivity (82% vs 58%, P = 0.00005) and higher negative predictive value (npv = 76% vs 58%, P = 0.008) than CE alone. In women < 45 years, CE + USG had higher sensitivity (91% vs 76%, P = 0.037) and npv (89% vs 67%, P = 0.018) than in older women. The sensitivity and npv of CE + USG to detect > 1 positive node were 97% (for both) in women < 45 years compared to 81% and 79% in older women. The high sensitivity of CE + USG (82% for the whole group) is probably due to the higher proportion of young women (median age = 45) in our population. It suggests that using CE + USG to avoid axillary dissection in some patients is feasible.


Cancer | 1985

Anterior chemotherapy in esophageal cancer

Advani Sh; Tapan K. Saikia; Shanti Swaroop; Gopal Ramakrishnan; Nair Cn; Ketayun A. Dinshaw; Sanjay Sharma; J. J. Vyas; Praful B. Desai

Front loading chemotherapy using methotrexate (200 mg/m2) alone or methotrexate (200 mg/m2) with cisplatin (20 mg/m2 daily for 5 days) was used in epidermoid carcinoma of esophagus. Evaluation after two courses showed objective response of 50% or greater in 48% of patients with metbotrexate alone. Response rate was increased to 76.2% with addition of cisplatin to methotrexate. Small lesions (less than 10 cm) showed better response as compared to advanced cases. Therapy was generally well tolerated and good palliation was obtained even after the first course. Postchemotherapy treatment either with surgery or radiotherapy was tolerated without any major complications. The data confirm the short‐term usefulness of initial chemotherapy with methotrexate and cisplatin in esophageal cancer. Results of prolonged follow‐up will help to evaluate the role of front loading chemotherapy on long‐term survival. Cancer 56: 1502‐1506, 1985.


Asian Cardiovascular and Thoracic Annals | 2000

Atypical Carcinoid Tumors of Lung: Clinicopathologic Study of Six Cases

Girish Moghe; Nirmala A. Jambhekar; Ramakant K. Deshpande; Rahul Hejmadi; J. J. Vyas

This retrospective study of 6 cases of atypical carcinoid tumor was carried out to highlight their clinicopathological features and behavior. All patients were over 40 years of age and were treated by surgical excision of the tumor. Four tumors were central and 2 were peripherally located in the lung. Grossly, the tumors were large with spotted areas of necrosis. Microscopically, all tumors had a typical carcinoid pattern with spotted areas of necrosis and mitotic activity in the range of 2 to 5 per 10 high-power fields. On immunohistochemistry, the tumors were positive for neuron-specific enolase and cytokeratin. Follow-up ranging from 1 to 5 years was available in 4 patients; 2 are currently alive, 1 with local recurrence and distant metastasis one year postoperatively, the other with no disease after 5 years. Two patients died; one had a local recurrence at 2 years and the other had liver metastasis at 3 years.


Cell Biology International Reports | 1992

De novo biosynthesis and localization of immunoreactive inhibin (10.7 kDa) in normal human stomach

Aditi A. Kapasi; Pranoti S. Mandrekar; Anil D'Cruz; J. J. Vyas; Nandini A. Sheth

We have previously reported the occurrence of inhibin-like peptide in gastric juice of normal men. In the present investigation, normal gastric mucosa was shown to synthesize inhibin, in vitro, as measured by 3H-leucine incorporation (Maximum at 18 h). Furthermore, the immunohistochemical localization studies demonstrated its presence in the acid secreting parietal cells and basal region of foveolar epithelium of gastric mucosa. Surprisingly, the protein secreting zymogen cells remained unstained.


Journal of Surgical Oncology | 1983

Multiple primary cancers in Indian population: metachronous and synchronous lesions.

J. J. Vyas; Raman K. Deshpande; Sanjay Sharma; P. B. Desai


Journal of Surgical Oncology | 1983

Immunity in esophageal carcinoma.

Advani Sh; P. M. Kutty; R. Gopal; S. Swaroop; Nair Cn; Ketayun A. Dinshaw; S. R. Damle; J. S. Nadkarni; P. N. Akolkar; B. P. Gothaskar; J. J. Vyas; P. B. Desai


Journal of Surgical Oncology | 1986

Adjuvant chemotherapy in Ewing's sarcoma

Advani Sh; D. N. Rao; Ketayun A. Dinshaw; Nair Cn; R. Gopal; J. J. Vyas; P. B. Desai


Seminars in Surgical Oncology | 1989

Combined treatment modalities in esophageal cancer

P. B. Desai; J. J. Vyas; Sanjay Sharma; Raman K. Deshpande; Rajan Badwe; Advani Sh; Tapan K. Saikia; Ketayun A. Dinshaw; V. Santhi Swaroop

Collaboration


Dive into the J. J. Vyas's collaboration.

Top Co-Authors

Avatar

P. B. Desai

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Advani Sh

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nair Cn

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Rajan Badwe

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Js Vaidya

University College London

View shared research outputs
Top Co-Authors

Avatar

D. N. Rao

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge